Related Articles
Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
Comprehensive analysis of excision repair complementation group 1, glutathione S-transferase, thymidylate synthase and uridine diphosphate glucuronosyl transferase 1A1 polymorphisms predictive for treatment outcome in patients with advanced gastric cancer treated with FOLFOX or FOLFIRI
Individualized chemotherapy guided by the expression of <em>ERCC1, RRM1, TUBB3, TYMS</em> and <em>TOP2A</em> genes versus classic chemotherapy in the treatment of breast cancer: A comparative effectiveness study
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy